Provides IVF treatments, including egg donation, to people seeking fertility care, and refers customers seeking IVF or surrogacy services to independent agents.
20-F for FY2025, filed Mar 31, 2026
Individual customers generally pay for IVF treatment in advance; entity customers have 30-day credit terms, and the clinic earns its fee when treatment procedures are completed. For referrals, the company earns a fee from an agent once the referral is accepted and the agent receives subsequent income.
20-F for FY2025, filed Mar 31, 2026
20-F for FY2025, filed Mar 31, 2026
FY2025 revenue by product or service ↗$4.7M
20-F for FY2025, filed Mar 31, 2026
$4.7M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
IVF treatment service
Sold outright
20-F for FY2025, filed Mar 31, 2026 |
83%
FY2022: 47%
|
IVF treatment service, FY2025
$3.9M Sources
|
Sold outright |
|
Fertility referral services
Sold outright
20-F for FY2025, filed Mar 31, 2026 |
17% |
Fertility referral services, FY2025
$820.6K Sources
|
Sold outright |
Patients make verbal agreements with NewGenIvf for treatment, while customers seeking IVF or surrogacy referrals are connected to independent agents.
20-F for FY2025, filed Mar 31, 2026
Yes. Its net income in FY2025 was larger than its revenue, but spent more cash than it brought in: free cash flow was −$11.1M.
20-F for FY2025, filed Mar 31, 2026
−$10.7MView ↗
20-F for FY2025, filed Mar 31, 2026
$9.9MView ↗
20-F for FY2025, filed Mar 31, 2026
−$11.1MView ↗
Growing. Revenue grew 15% in 4 years, from $4.1M in FY2021 to $4.7M in FY2025, about 4% a year.
Loading...